Aicaigou LogoB2B WikiIndustrial Encyclopedia

Bortezomib

Updated: 2026-07-17

Overview

Bortezomib is a boronic acid dipeptide derivative and the first proteasome inhibitor approved for clinical use. It was developed by Millennium Pharmaceuticals and received FDA approval in 2003 for treating relapsed multiple myeloma. The drug works by reversibly inhibiting the 26S proteasome, leading to the accumulation of polyubiquitinated proteins and subsequent apoptosis in cancer cells. Bortezomib has shown significant efficacy in hematological malignancies, particularly in combination therapies. Its introduction marked a breakthrough in targeted cancer treatment, offering improved outcomes for patients with refractory or relapsed disease.

Physical and Chemical Properties

硼替佐米中间体 有机化工原料 179324-87-9 桶装粉末 支持试样江苏博思特化工科技有限公司

Bortezomib is a small molecule with a molecular weight of 384.24 g/mol, appearing as a white to off-white powder. It is sparingly soluble in water but dissolves well in dimethyl sulfoxide (DMSO), a property that influences its pharmaceutical formulation. The compound contains a boronic acid functional group, which is crucial for its mechanism of action. The drug exhibits stability under recommended storage conditions (-20°C, protected from light and moisture), but may degrade when exposed to heat or humidity. Its melting point ranges between 122-124°C, and it demonstrates pH-dependent stability, being most stable in slightly acidic conditions.

商家经验真实案例 · 安全可信
碳酸镍含镍量揭秘
本文解析碳酸镍中镍的质量分数计算方法,探讨其工业应用价值,并揭示影响镍含量的关键因素,帮助读者全面了解这一重要工业原料。

Main Applications

Bortezomib is primarily used in the treatment of multiple myeloma, both as a first-line therapy and for relapsed/refractory cases. It is also approved for mantle cell lymphoma in patients who have received at least one prior therapy. The drug is typically administered intravenously or subcutaneously in combination with other chemotherapeutic agents or corticosteroids. Beyond its approved indications, bortezomib is being investigated for various other malignancies, including solid tumors and autoimmune disorders. Its ability to modulate NF-κB signaling makes it a candidate for conditions where this pathway is dysregulated.

Safety and Storage

硼替佐米中间体 179324-87-9 高含量 规格多样 可分装湖北健楚生物医药有限公司

Bortezomib requires careful handling due to its cytotoxic nature. Healthcare workers should use personal protective equipment when preparing or administering the drug. Common adverse effects include peripheral neuropathy, thrombocytopenia, fatigue, and gastrointestinal disturbances. For storage, bortezomib should be kept at -20°C in its original packaging to protect from light and moisture. Reconstituted solutions are stable for limited periods under refrigeration. Proper inventory management is essential to prevent wastage of this high-value pharmaceutical.

商家经验真实案例 · 安全可信
麝香产香量大揭秘
本文揭秘麝香产香量,包括麝香腺体结构、产香频率与量,以及影响产香量的因素,带你全面了解麝香的产香奥秘。

B2B Procurement Guide

When procuring bortezomib, buyers should verify the supplier's Good Manufacturing Practice (GMP) certification and request batch-specific certificates of analysis. Due to its therapeutic importance and cost, consider establishing long-term contracts with reputable manufacturers to ensure supply chain stability. Quality control should include verification of purity (typically >98%), residual solvents, and microbiological limits. For international shipments, ensure compliance with cold chain requirements and customs regulations for controlled substances. Pricing is often negotiated based on volume and may include value-added services like stability testing.

Related Manufacturers